The potential of leaf extract of Pangium edule Reinw as HIV-1 protease inhibitor: A computational biology approach

SG Tumilaar, F Fatimawali, NJ Niode… - Journal of Applied …, 2021 - japsonline.com
Abstract The leaf of Pangi (Pangium edule) is used as food in North Sulawesi. According to
a study conducted in vitro, Pangi leaf extract suppressed the replication of the human …

Anti-HIV agents: current status and recent trends

A Geronikaki, P Eleftheriou, V Poroikov - Communicable Diseases of the …, 2018 - Springer
Human immunodeficiency virus is responsible for acquired immunodeficiency syndrome
(AIDS), an infectious disease that consists a serious concern worldwide for more than three …

New prospects for nelfinavir in non-HIV-related diseases

A Bruning, A Gingelmaier, K Friese… - Current Molecular …, 2010 - ingentaconnect.com
Nelfinavir (Viracept®) was originally designed as a specific HIV protease inhibitor and, since
its introduction in 1997, has served as an effective, reliable, and well-tolerated HIV drug …

Design and evaluation of novel piperidine HIV-1 protease inhibitors with potency against DRV-resistant variants

M Zhu, H Zhou, L Ma, B Dong, J Zhou, G Zhang… - European Journal of …, 2021 - Elsevier
A novel class of HIV-1 protease inhibitors with flexible piperidine as the P2 ligand was
designed with the aim of improving extensive interactions with the active subsites. Many …

In silico approach in drug design and drug discovery: an update

N Jabalia, A Kumar, V Kumar, R Rani - Innovations and Implementations …, 2021 - Springer
Drug design and drug discovery is a passionate, prolonged, and inter-disciplinary multistep
process. The traditional drug discovery process is costly and time-consuming which …

Design and biological evaluation of cinnamic and phenylpropionic amide derivatives as novel dual inhibitors of HIV-1 protease and reverse transcriptase

M Zhu, Q Shan, L Ma, J Wen, B Dong, G Zhang… - European journal of …, 2021 - Elsevier
Upon the basis of both possible ligand-binding site interactions and the uniformity of key
residues in active sites, a novel class of HIV-1 PR/RT dual inhibitors was designed and …

Substrate recognition in HIV-1 protease: a computational study

MAS Perez, PA Fernandes… - The Journal of Physical …, 2010 - ACS Publications
HIV-1 protease is a crucial enzyme for the life cycle of the human immunodeficiency virus,
the retrovirus that triggers AIDS. It is well documented that HIV-1 protease mediates the …

New Insights into the In Silico Prediction of HIV Protease Resistance to Nelfinavir

DA Antunes, MM Rigo, M Sinigaglia, RM de Medeiros… - PLoS …, 2014 - journals.plos.org
The Human Immunodeficiency Virus type 1 protease enzyme (HIV-1 PR) is one of the most
important targets of antiretroviral therapy used in the treatment of AIDS patients. The success …

Novel HIV-1 protease inhibitors with morpholine as the P2 ligand to enhance activity against DRV-resistant variants

M Zhu, Y Dou, L Ma, B Dong, F Zhang… - ACS Medicinal …, 2020 - ACS Publications
Flexible heterocyclic moieties as the P2 ligands of HIV-1 protease inhibitors may be adapted
to the minimally distorted active site of mutations easily and enhance activity against DRV …

Indolizine Studies, Part 5: Indolizine-2-carboxamides as Potential HIV-1 Protease Inhibitors[ ]

M Tukulula, R Klein, PT Kaye - Synthetic Communications®, 2010 - Taylor & Francis
Full article: Indolizine Studies, Part 5: Indolizine-2-carboxamides as Potential HIV-1 Protease
Inhibitors[ 1 ] Skip to Main Content Taylor and Francis Online homepage Taylor and Francis …